NPCE - Neuropace - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NPCE is currently covered by 2 analysts with an average price target of $15.06. This is a potential upside of $4.27 (39.57%) from yesterday's end of day stock price of $10.79.

Neuropace's activity chart (see below) currently has 49 price targets and 28 ratings on display. The stock rating distribution of NPCE is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 53.86% with an average time for these price targets to be met of 137.71 days.

Highest price target for NPCE is $17, Lowest price target is $15, average price target is $16.

Most recent stock forecast was given by VIK CHOPRA from WELLS FARGO on 13-Aug-2025. First documented stock forecast 17-May-2021.

Currently out of the existing stock ratings of NPCE, 3 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$15

$4.8 (47.06%)

$13

1 months 26 days ago
(13-Aug-2025)

2/3 (66.67%)

$5.68 (60.94%)

171

Buy

$16

$5.08 (46.52%)

$14

4 months 25 days ago
(14-May-2025)

3/4 (75%)

$0.4 (2.56%)

156

Buy

$17

$6.8 (66.67%)

$20

4 months 25 days ago
(14-May-2025)

4/5 (80%)

$1.4 (8.97%)

179

Buy

$20

$9.08 (83.15%)

$20

1 years 5 months 3 days ago
(06-May-2024)

2/4 (50%)

$6.53 (48.48%)

175

Buy

$20

$9.8 (96.08%)

$16

1 years 6 months 25 days ago
(14-Mar-2024)

5/8 (62.5%)

$6.37 (46.74%)

266

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is NPCE (Neuropace) average time for price targets to be met?

On average it took 137.71 days on average for the stock forecasts to be realized with a an average price target met ratio 53.86

Which analyst has the current highest performing score on NPCE (Neuropace) with a proven track record?

ROSS OSBORN

Which analyst has the current lower performing score on NPCE (Neuropace) with a proven track record?

MIKE POLARK

Which analyst has the most public recommendations on NPCE (Neuropace)?

Ross Osborn works at CANTOR FITZGERALD and has 9 price targets and 7 ratings on NPCE

Which analyst is the currently most bullish on NPCE (Neuropace)?

Mike Polark with highest potential upside - $11.39

Which analyst is the currently most reserved on NPCE (Neuropace)?

Drew Ranieri with lowest potential downside - $1.39

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?